Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00474175 · ClinicalTrials.gov registry record · Phase 4

Benzocaine Gel Toothache Dose-Response Study

A Phase 4 study, sponsored by Wyeth is now a wholly owned subsidiary of Pfizer.

Completed
Registry status
Phase 4
Development phase
577
Enrollment target

NCT00474175: Completed Phase 4 study, sponsored by Wyeth is now a wholly owned subsidiary of Pfizer.

NCT00474175 is a Phase 4 study that has completed, run by Wyeth is now a wholly owned subsidiary of Pfizer. The registered enrollment target is 577 participants, above the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (11% higher). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00474175, a Phase 4 study, has completed, sponsored by Wyeth is now a wholly owned subsidiary of Pfizer.

COMPLETED
Registry status
Phase 4
Development phase
577 participants
Enrollment target

Study Summary

To evaluate the efficacy and safety of benzocaine gel products for the relief of toothache and to assess the subject's compliance with proposed label directions.

Primary Outcome

Responder was defined as participant experiencing improvement in pain intensity, as exhibited by a pain score reduction on the Dental Pain Scale (DPS) from baseline of at least 1 unit for two consecutive assessments anytime between the 5 and 20-minute time points. Response in DPS scale was assigned values as 0 (None), 1 (Mild), 2 (Moderate) and 3 (Severe).

Interventions

  • DRUG Placebo gel
  • DRUG benzocaine

Trial Details

FieldValue
Enrollment Target 577 participants
Start Date 2007-05
Est. Completion 2010-12
Phase Phase 4

What the finished NCT00474175 record still lists

NCT00474175 is an interventional study that assigns participants to a tested intervention. The registered 577 participants enrollment target is mid-sized for trials with a published cap, above the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (11% higher).

The record links to 0 conditions, and to 2 interventions - of which Placebo gel is the first listed.

NCT00474175 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00474175 about?

NCT00474175 is a clinical study titled "Benzocaine Gel Toothache Dose-Response Study". To evaluate the efficacy and safety of benzocaine gel products for the relief of toothache and to assess the subject's compliance with proposed label directions.

What is the current status of trial NCT00474175?

This trial is currently completed. It is a Phase 4 study. The enrollment target is 577 participants. The study started on 2007-05. Estimated completion is 2010-12.

What interventions are being tested in trial NCT00474175?

The interventions under investigation include: Placebo gel (DRUG), benzocaine (DRUG).

Who is sponsoring clinical trial NCT00474175?

This trial is sponsored by Wyeth is now a wholly owned subsidiary of Pfizer, which has 167 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00474175's enrollment target sits among peer trials

577 149th of 2000 higher than 1,851 of 2,000 other Phase 4 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT07290543 · 578 participants · NA

    Web-Based Toolkit to Improve Cancer-Related Emotional Distress and Anxiety in Rural Older Cancer Survivors

  • NCT04931810 · 576 participants · NA

    Urban and Reservation Implementation of All Nations Breath of Life

  • NCT05179369 · 576 participants · NA

    Well-Mama Community Doula Navigator Study

  • NCT06398509 · 576 participants · NA

    A Primary Care Based Intervention to Prevent Childhood Obesity Among Low-income Latino Children

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00474175, the US trial registry maintained by the National Library of Medicine. NCT00474175 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.